slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,369
Current window 32,191-32,220
Pages 1,379
Rows per page 30
Component
32,191-32,220 of 41,369
10
Includes a Time Magazine 'Invention of the Year' callout and a list of 8 specific FDA milestones.23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations Beat · Traction1 hit
20
The slide uses a 4-column layout to categorize service offerings, each paired with a mobile app UI screenshot.23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations Beat · Solution1 hit
24
The slide features a '4' in a circle, suggesting it is the fourth section of the deck. The background is decorated with DNA base pairs (A, T, C, G).23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations 1 hit
40
The slide uses heatmaps to show genetic associations, contrasting immune and cancer phenotypes for specific proteins.23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
49
The slide features a gradient background with scattered DNA base letters (A, T, C, G) and a large number '5' in a circle, indicating it is the fifth section.23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations 1 hit
53
Includes a callout highlighting the growth in Therapeutics R&D investment.23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations 1 hit
11
The slide uses a green callout box to emphasize the deal structure.AbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Evidence & Proof1 hit
11
The slide uses a circular process diagram to represent the flywheel effect of their platform.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Solution1 hit
13
The slide uses a process flow diagram to illustrate the transition from biological wet-lab data generation to AI model training.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
15
The diagram is a circular flywheel process showing the integration of data, wet lab validation, and AI creation.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · Action1 hit
07
Includes two testimonials from Key Opinion Leaders (KOLs) to emphasize the patient burden.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
10
The slide outlines a multi-part clinical trial design with specific dosing cohorts and patient eligibility requirements.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution1 hit
12
Aeglea BioTherapeutics | Investor Presentation Deck | 37 slidesAeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution1 hit
13
ADA stands for Anti-Drug Antibodies.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution1 hit
17
The slide presents two distinct clinical metrics: a box plot for arginine levels and a bar chart for patient response rates.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Loop · Jobs To Be Done1 hit
18
Clinical trial data presentation with statistical significance markers and MCID thresholds.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Loop · Jobs To Be Done1 hit
19
The slide uses a heatmap to visualize individual patient outcomes, highlighting clinical improvement vs. worsening.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Loop · Jobs To Be Done1 hit
20
Clinical trial safety data comparing Pegzilarginase to Placebo.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Loop · Jobs To Be Done1 hit
24
The slide uses a biological pathway diagram to explain the mechanism of action of the drug candidate.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
36
The table highlights specific clinical response metrics for six individual patients, demonstrating improvements and normalization of mobility scores.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations 1 hit
03
The slide uses a three-column layout to categorize ESG commitments.UBS | ESG Presentation Deck | 35 slides · UBS
Shareholder letter Investor relations Beat · ProblemLoop · Golden Circle1 hit
04
UBS | Mergers and Acquisitions Presentation Deck | 12 slidesUBS | Mergers and Acquisitions Presentation Deck | 12 slides · UBS
Conference presentation Investment bank 1 hit
06
The 2023 bar is marked as illustrative.UBS | Shareholder Engagement Presentation Deck | 21 slides · UBS
Shareholder letter Investor relations Beat · Shareholder Returns1 hit
07
The 2023 data point is marked as illustrative.UBS | Shareholder Engagement Presentation Deck | 21 slides · UBS
Shareholder letter Investor relations Beat · Shareholder Returns1 hit
14
Includes a specific motion for shareholder ratification.UBS | Shareholder Engagement Presentation Deck | 21 slides · UBS
Shareholder letter Investor relations Beat · SustainabilityLoop · Golden Circle1 hit
19
Includes a reference to a specific external report on the French cross-border matter.UBS | Shareholder Engagement Presentation Deck | 21 slides · UBS
Shareholder letter Investor relations 1 hit
12
Vivid Seats | Results Presentation Deck | 23 slidesVivid Seats | Results Presentation Deck | 23 slides · Vivid Seats
Conference presentation Investor relations Beat · FinancialsLoop · Why Now1 hit
10
Slide highlights brand-specific marketing initiatives alongside strong financial growth metrics.Yatsen | Results Presentation Deck | 19 slides · Yatsen
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
11
The chart illustrates a strategic reduction in physical retail footprint, attributed to COVID-19 impact.Yatsen | Results Presentation Deck | 19 slides · Yatsen
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
18
The chart displays quarterly operating cashflow (bars) and total cash/investment balances (ovals).Yatsen | Results Presentation Deck | 19 slides · Yatsen
Conference presentation Investor relations Beat · Visualization1 hit